1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
Overactive Bladder Treatment Market by Pharmacotherapy, Disease Type - Global Forecast to 2022

Overactive Bladder Treatment Market: Global Forecast until 2022

  • July 2017
  • 244 pages
  • ID: 5043162
In this report:
In 2015, ##.##% of the German population was above the age of ## years; by 2050, this age group is expected to account for ##.##% of the total population.
The percentage of the aging population (aged ## years and above) in the country is expected to grow from ##.##% in 2015 to ##.##% by 2030.
The geriatric population (aged ## years and over) in Asia is expected to increase to ##.##% by 2030 from ##.##% in 2015, showing a ##.##% growth.


Table of Contents

Search Inside

"Global overactive bladder treatment market is estimated to rise at a compound annual growth rate of 2.90 percent."

The overall overactive bladder treatment market is forecasted to grow at a compound annual growth rate (CAGR) of 2.90 percent between 2017 and 2022, to attain ~$4.2B by 2022. The main key factors driving the increase of this market contain the growing prevalence of overactive bladder coupled with the increasing geriatric population and increasing neurological disorders, that is, Parkinson's Disease, stroke, and multiple sclerosis. Nevertheless, the undesired systemic effects of current OAB treatments may hinder the rise of the market to a certain extent during the estimate period.

"The neurostimulation and BOTOX treatment segments are anticipated to grow at the highest compound annual growth rate (CAGR)."

On the basis of pharmacotherapy, the overactive bladder treatment market is broken down into anticholinergics, mirabegron, BOTOX, and neurostimulation. The neurostimulation and BOTOX treatment segments are forecasted to witness the highest rise during the outlook period. The rise of these segments is primarily due to the higher efficacy and longevity of the treatment effects as distinguished to anticholinergics.

"The solifenacin to lead the overall overactive bladder treatment market during the estimate period."

Established on anticholinergic drugs, the overactive bladder treatment market is further classified into darifenacin, fesoterodine, oxybutynin, solifenacin, tolterodine, trospium, and other anticholinergics (imidafenacin, emepronium, flavoxate, meladrazine, terodiline, propiverine, and desfesoterodine). Solifenacin is anticipated to command for the most important share of the overall overactive bladder treatment market according to its efficacy as distinguished to other drugs of its class.

"RoAPAC to witness the more significant increase during the outlook period (2017-2022)"

The U.S.A held the biggest share of the overall overactive bladder treatment market in 2016, while the Rest of Asia-Pac is anticipated to witness the highest increase during 2017 to 2022. Increasing healthcare expenditure in territories such as India (IN), China (CN), and Singapore (SG); favorable demographics; and aggressive marketing by pharma firms leading to growing awareness on OAB are the top factors responsible for the increase of this market in the RoAPAC area.

Break of primary members taking part was as mentioned below:

• By Company category - Tier 1 - 60.0 percent, Tier 2 - 25.0 percent and Tier 3 - 15.0 percent

• By Description - C-suite - 17.0 percent, D-level - 45.0 percent, Others - 38.0 percent

• By Area - North America continent - 42.0 percent, Europe (EU) - 28.0 percent, Asia Pacific (APAC) - 17.0 percent, RoW - 13.0 percent

Some of the main market actors in the overactive bladder treatment market are Astellas Pharma, Incorporated, Pfizer, Incorporated, Teva Pharmaceutical Industries Limited, Allergan, Plc, Medtronic (NYSE:MDT), Mylan N.V., Endo International plc, Hisamitsu Pharmaceutical Co., Incorporated, Sanofi, Aurobindo Pharma Limited, Apotex, Incorporated, and Cogentix Medical, Incorporated.

Segment Research

The market research examines the overactive bladder treatment market and aims at estimating the market value and upcoming growth potential of this market established on several segments including pharmacotherapy, disease type, and area. The industry report also comprises an detailed regulatory study for several areas across the world and competitive review of the top actors in this sector together with their company descriptions, product offerings, latest developments, and key industries strategies.

Reasons to Buy the Report

The study will increase established companies as well as new entrants/smaller companies to measure the pulse of the sector, which in turn would benefit them, collect a greater share. Companies obtaining the analysis could use one or any combination of the below-mentioned five strategies.

This industry report offers business insights on these pointers:

• Market Uptake: Exhaustive data on product types provided by the top actors in the overall overactive bladder treatment market. The market research examines the overall overactive bladder treatment market by pharmacotherapy, disease type, and area.

• Product Innovation: In-depth understanding on upcoming trends and recent product launches in the overall overactive bladder treatment market

• Market Development: Highlighted information on the profitable emerging sectors by pharmacotherapy, disease type, and area

• industry diversification: Complete information about recent products, increasing geographies, recent evolutions, and market investments in the overall overactive bladder treatment market

• opposing assessment: Detailed assessment of market shares, increase strategies, products, and drugs in pipeline of leading actors in the overall market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Urinary Incontinence - Pipeline Insight, 2017

Urinary Incontinence - Pipeline Insight, 2017

  • $ 1250
  • Industry report
  • November 2017
  • by Delve Insight

DelveInsight’s, “Urinary Incontinence -Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Urinary Incontinence .The report ...

Global Urinary Slings Market 2017-2021

Urinary Slings Sector: Worldwide Forecast until 2021

  • $ 3500
  • Industry report
  • February 2017
  • by Infiniti Research Limited

About Urinary SlingsThe global urinary slings market will grow rapidly at the rate of 10.12% during the forecast period, primarily due to a high prevalence of urinary incontinence, propelling the consumption ...

Urinary Incontinence Devices Market in Japan 2017-2021

Urinary Incontinence Devices Sector: Forecast until 2021 in Japan

  • $ 3500
  • Industry report
  • September 2017
  • by Infiniti Research Limited

About Urinary Incontinence DevicesThe urinary incontinence devices are used to manage different types of urinary incontinence such as stress incontinence, mixed incontinence, urge incontinence, and overflow ...


Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.